Liposomal-formulated curcumin [Lipocurc™] targeting HDAC (histone deacetylase) prevents apoptosis and improves motor deficits in Park 7 (DJ-1)-knockout rat model of Parkinson's disease: implications for epigenetics-based nanotechnology-driven drug p (Q47833362)
Jump to navigation
Jump to search
scientific article published on 7 November 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Liposomal-formulated curcumin [Lipocurc™] targeting HDAC (histone deacetylase) prevents apoptosis and improves motor deficits in Park 7 (DJ-1)-knockout rat model of Parkinson's disease: implications for epigenetics-based nanotechnology-driven drug p |
scientific article published on 7 November 2013 |
Statements
1 reference
Liposomal-formulated curcumin [Lipocurc™] targeting HDAC (histone deacetylase) prevents apoptosis and improves motor deficits in Park 7 (DJ-1)-knockout rat model of Parkinson's disease: implications for epigenetics-based nanotechnology-driven drug p (English)
1 reference
Simon Chiu
1 reference
Kristen J Terpstra
1 reference
Yves Bureau
1 reference
Jirui Hou
1 reference
Hana Raheb
1 reference
Zack Cernvosky
1 reference
Vladimir Badmeav
1 reference
John Copen
1 reference
Mariwan Husni
1 reference
Michael Woodbury-Farina
1 reference
7 November 2013
1 reference
10
1 reference
1 reference
Identifiers
1 reference
1 reference